Michael Millward

Professor, MB BS W.Aust., MA Melb., FRACP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 7547 Citations
  • 37 h-Index
20042024
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Cancer
  • Clinical trials

Fingerprint Dive into the research topics where Michael Millward is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Survival Medicine & Life Sciences
Mutation Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2020

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials

Hauschild, A., Ascierto, P. A., Schadendorf, D., Grob, J. J., Ribas, A., Kiecker, F., Dutriaux, C., Demidov, L. V., Lebbé, C., Rutkowski, P., Blank, C. U., Gutzmer, R., Millward, M., Kefford, R., Haas, T., D'Amelio, A., Gasal, E., Mookerjee, B. & Chapman, P. B., Jan 2020, In : European Journal of Cancer. 125, p. 114-120 7 p.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Melanoma
Dacarbazine
Disease-Free Survival
dabrafenib

A panel of circulating MicroRNAs detects uveal melanoma with high precision

Stark, M. S., Gray, E. S., Isaacs, T., Chen, F. K., Millward, M., McEvoy, A., Zaenker, P., Ziman, M., Soyer, H. P., Glasson, W. J., Warrier, S. K., Stark, A. L., Rolfe, O. J., Palmer, J. M. & Hayward, N. K., Nov 2019, In : Translational Vision Science and Technology. 8, 6, 12.

Research output: Contribution to journalArticle

Open Access
MicroRNAs
Nevus
Blood
Biopsy
Real time systems

A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors

Goh, J., Gao, B., Markman, B., Gan, H., Voskoboynik, M., Wu, Y-L., Guo, J., Zhou, Q., Zhao, J., Chen, C., Qiu, J., Xu, Y., Yang, L. & Millward, M., Jul 2019, In : Cancer Research. 79, 13, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer

Pavlakis, N., Cooper, C., John, T., Kao, S., Klebe, S., Lee, C. K., Leong, T., Millward, M., O'Byrne, K., Russell, P. A., Solomon, B., Cooper, W. A. & Fox, S., 1 Dec 2019, In : Pathology. 51, 7, p. 673-680 8 p.

Research output: Contribution to journalEditorial

Practice Guidelines
Non-Small Cell Lung Carcinoma
Consensus
Protein-Tyrosine Kinases
Neoplasms

Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report

Calapre, L., Warburton, L., Millward, M. & Gray, E. S., 14 Nov 2019, In : BMC Cancer. 19, 1, 1109.

Research output: Contribution to journalArticle

Open Access
Colorectal Neoplasms
Melanoma
Biomarkers
DNA
Neoplasms

Projects 2004 2024